PATENT CLAIM ANALYSIS

Application Number: 15771317
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to a method and composition for use in treating a condition that benefits from the reduction of hepatic and/or visceral fat, such as polycystic ovary syndrome in adolescent girls or women of childbearing age, involving the use of spironolactone, pioglitazone and metformin.

Claim (Index 52):
The method according to  claim 42 , wherein said administering comprises the daily administration of between 25 and 100 mg spironolactone.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.21951
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10317126', '15522599', '14535810', '14843873', '15119695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7324323768438303
- 35 USC 102 Novelty (BERT): 0.5000806506358797
- Combined Prediction Score: 0.7091972042230353
- Mean Citation Score: 203.706706
- Max Citation Score: 229.1751
- Similarity Product: 159.46621031933427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test